CSIMarket
 
Akari Therapeutics Plc  (NASDAQ: AKTX)
 

Akari Therapeutics Plc's Customers Performance

AKTX



 
AKTX's Source of Revenues

List of AKTX Customers




for the same period Akari Therapeutics Plc

List of AKTX Customers





Akari Therapeutics Plc's Comment on Sales, Marketing and Customers





  News about Akari Therapeutics Plc Contracts

Akari Therapeutics Interim CEO Demonstrates Commitment to Shareholder Alignment

In a recent announcement, biotechnology company Akari Therapeutics Plc (Nasdaq: AKTX) has provided details about the employment contract of i...












AKTX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Akari Therapeutics Plc 1,167,381.44 0.00 -28.05 6
SUBTOTAL 0.00 0.00 0.00 -

Sources: Akari Therapeutics Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Akari Therapeutics Plc’s corporate clients.
For your research, we’ve provided 9 tables on Akari Therapeutics Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.